Literature DB >> 16934711

Plague: a review of its history and potential as a biological weapon.

B Lee Ligon1.   

Abstract

The increased threat of terrorism has revealed the importance of various diseases as potential weapons of destruction. Among the diseases that have been identified by the Centers for Disease Control and Prevention as being caused by category A organisms is plague. An ancient disease, it has played a role in both natural disasters and war and has been used as a weapon since at least medieval times. This article provides a brief historical overview of the disease in its natural occurrence and in its use as a biological weapon, as well as its potential for future use.

Mesh:

Year:  2006        PMID: 16934711     DOI: 10.1053/j.spid.2006.07.002

Source DB:  PubMed          Journal:  Semin Pediatr Infect Dis        ISSN: 1045-1870


  22 in total

1.  Structure of the cytoplasmic domain of Yersinia pestis YscD, an essential component of the type III secretion system.

Authors:  George T Lountos; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-02-07

2.  Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.

Authors:  Christina J van Lier; Jian Sha; Michelle L Kirtley; Anthony Cao; Bethany L Tiner; Tatiana E Erova; Yingzi Cong; Elena V Kozlova; Vsevolod L Popov; Wallace B Baze; Ashok K Chopra
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 3.  Cultural Biases in Current Medical Practices with a Specific Attention to Orthopedic Surgery: a Review.

Authors:  Gracia Etienne; Todd P Pierce; Anton Khlopas; Morad Chughtai; Carlos J Lavernia; Teva Y Vogelstein; Craig M Thomas; Charles S Modlin; Michael A Mont
Journal:  J Racial Ethn Health Disparities       Date:  2017-07-17

4.  Structural characterization of the Yersinia pestis type III secretion system needle protein YscF in complex with its heterodimeric chaperone YscE/YscG.

Authors:  Ping Sun; Joseph E Tropea; Brian P Austin; Scott Cherry; David S Waugh
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

5.  Atomic resolution structure of the cytoplasmic domain of Yersinia pestis YscU, a regulatory switch involved in type III secretion.

Authors:  George T Lountos; Brian P Austin; Sreedevi Nallamsetty; David S Waugh
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

6.  Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Authors:  Tatiana E Erova; Jason A Rosenzweig; Jian Sha; Giovanni Suarez; Johanna C Sierra; Michelle L Kirtley; Christina J van Lier; Maxim V Telepnev; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

7.  Characterization of Yersinia species by protein profiling using automated microfluidic capillary electrophoresis.

Authors:  Victoria M Bennett; Dennis McNevin; Paul Roffey; Michelle E Gahan
Journal:  Forensic Sci Med Pathol       Date:  2016-12-26       Impact factor: 2.007

8.  A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.

Authors:  Jian Sha; Jason A Rosenzweig; Michelle L Kirtley; Christina J van Lier; Eric C Fitts; Elena V Kozlova; Tatiana E Erova; Bethany L Tiner; Ashok K Chopra
Journal:  Microb Pathog       Date:  2012-10-09       Impact factor: 3.738

9.  Comparative Global Gene Expression Profiles of Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant at Flea and Human Body Temperatures.

Authors:  Cristi L Galindo; Jian Sha; Scott T Moen; Stacy L Agar; Michelle L Kirtley; Sheri M Foltz; Lauren J McIver; E V Kozlova; Harold R Garner; Ashok K Chopra
Journal:  Comp Funct Genomics       Date:  2010-05-19

10.  New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Authors:  Jourdan A Andersson; Eric C Fitts; Michelle L Kirtley; Duraisamy Ponnusamy; Alex G Peniche; Sara M Dann; Vladimir L Motin; Sadhana Chauhan; Jason A Rosenzweig; Jian Sha; Ashok K Chopra
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.